Understanding the CD163 - PRRS virus interaction to improve genetic engineering for resistance
Understanding the CD163 - PRRS virus interaction to improve genetic engineering for resistance
批准号:
BB/R004463/1
负责人:
Christine Tait-Burkard
金额:
$67.56万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
猪繁殖与呼吸综合征(PRRS)是猪的一种流行性病毒性疾病,造成重大经济损失。PRRS病毒(PRRSV)是一种快速进化的小包膜RNA病毒,是PRRS的病原体。虽然随着畜牧业和疫苗接种的变化,情况有所改善,但PRRS仍然对猪的健康和福利产生重大影响。PRRS约占美国养猪业传染病成本的三分之一,每年达6.5亿美元。PRRS是对欧洲、中国和北美养猪业造成最大损失的疾病,最近在中国和东南亚暴发的高致病性PRRSV变种表明,新的PRRSV变种具有更具破坏性的潜力。PRRSV具有狭窄的宿主细胞趋向性,仅限于单核细胞/巨噬细胞谱系的细胞。像所有病毒一样,PRRSV依靠宿主细胞机制进行自我复制并产生新的病毒颗粒。其中一种宿主蛋白CD163,已被发现是病毒通过膜融合从摄取囊泡进入过程中逃逸所必需的。CD163在巨噬细胞表面表达,细胞外部分CD163形成9个富含半胱氨酸的清道夫受体(SRCR)结构域的串上珍珠结构。SRCR结构域5 (SRCR5)被发现对PRRSV感染宿主细胞的能力至关重要。除了介导PRRSV感染外,CD163在宿主细胞内具有多种重要功能,例如从血液中去除血红蛋白-触珠蛋白复合物,从而阻止可能损害其他细胞的活性氧的形成。我最近与他人的研究表明,基因组编辑是对抗PRRSV感染的可行工具,并证实了CD163在这一过程中的重要性。另一个研究小组的工作表明,敲除CD163基因的猪对PRRSV感染具有抵抗力。然而,CD163在这些动物中的表达和功能被完全消除,因此它们从血液中去除血红蛋白/触珠蛋白复合物、缺血修复和炎症反应的能力可能受损。我的工作通过从猪基因组中删除编码外显子(deltaSRCR5)来去除SRCR5。我发现来自这些动物的巨噬细胞不仅对PRRSV感染具有抗性,而且在巨噬细胞表面表达截断的deltaSRCR5 CD163,同时保持血红蛋白-触珠蛋白清除功能。预计去除SRCR5并因此破坏“锁”,将取消PRRSV与其受体的键锁相互作用。因此,它阻止了PRRSV与宿主细胞膜的融合。然而,我们对CD163-PRRSV相互作用的了解还不够,无法排除这种高度诱变的RNA病毒适应deltaSRCR5细胞或猪的可能性。因此,我们需要进一步了解CD163 - PRRSV的相互作用,并深入了解PRRSV对deltaSRCR5修饰的适应能力。我对deltaSRCR5的研究表明,从CD163中去除单个外显子可以消除PRRSV感染,这强调了基因组编辑技术在诱导微妙遗传变化方面的巨大力量。该项目的目的是进一步评估CD163 - PRRSV相互作用和PRRSV适应deltaSRCR5猪的潜力,以及对猪基因组产生比目前deltaSRCR5猪更细微的变化。我提出以下策略来解决这些问题:鉴定与PRRSV相互作用的CD163结构域和氨基酸;评估PRRSV-CD163的信号传导和相互作用;在deltaSRCR5猪细胞上连续传代PRRSV,模拟病毒进化;通过外显子跳过而不是外显子缺失来产生功能性的deltaSRCR5猪。
英文摘要
Porcine Reproductive and Respiratory Syndrome (PRRS) is a panzootic viral disease of pigs that causes major economic losses. The causative agent of PRRS, PRRS virus (PRRSV) is a rapidly evolving small enveloped RNA virus. Whilst improvements have been effected with changes in husbandry and vaccination, PRRS still has major impacts on pig health and welfare. PRRS accounts for about a third of the cost of infectious disease to the US pig industry amounting to $650M per year. PRRS is the most costly disease to pig industries of Europe, China and North America and new PRRSV variants have the potential to be even more devastating as demonstrated by recent outbreaks of highly pathogenic variants of the virus in China and Southeast Asia. PRRSV has a narrow host cell tropism, limited to cells of the monocyte/macrophage lineage. Like all viruses PRRSV relies on the host cell machinery to replicate itself and generate new viral particles. One of these host proteins, CD163, has been found to be essential for the virus' escape from the uptake vesicle during the entry process by membrane fusion. CD163 is expressed on the surface of macrophages and the extracellular portion of CD163 forms a pearl-on-a-string structure of nine scavenger receptor cysteine-rich (SRCR) domains. SRCR domain 5 (SRCR5) was found to be essential for PRRSV's ability to infect a host cell. In addition to mediating PRRSV infection, CD163 has a variety of important functions within the host cell, such as removing haemoglobin-haptoglobin complexes from the blood, thereby preventing the formation of reactive oxygen species that could damage other cells.My recent research together with others demonstrated that genome editing is a viable tool to combat PRRSV infection and confirmed the importance of CD163 in in this process. Work by another research group has shown that pigs in which the CD163 gene was knocked-out are resistant to PRRSV infection. However, the expression and function of CD163 in these animals is completely abolished and thus their ability to remove haemoglobin/haptoglobin complexes from blood, ischaemic repair and inflammation response may be impaired. My work removed SRCR5 by deletion (deltaSRCR5) of the encoding exon from the pig genome. I found that macrophage cells from these animals were not only resistant to PRRSV infection but also expressed the truncated deltaSRCR5 CD163 on the macrophage surface whilst maintaining haemoglobin-haptoglobin scavenger function.It is expected that removal of SRCR5 and thereby destruction of the "lock" abrogates the key-lock interaction of PRRSV with its receptor. Thereby, it prevents fusion of PRRSV with the host cell membrane. However, we do not understand enough of the CD163-PRRSV interaction to exclude the potential for this highly mutagenic RNA virus to adapt to a deltaSRCR5 cell or pig. Therefore, we need further understanding of the CD163 - PRRSV interaction and insight into PRRSV's ability to adapt to the deltaSRCR5 modification. My research on deltaSRCR5 shows that removal of a single exon from CD163 can abolish PRRSV infection, emphasising the great power of genome editing technology to induce subtle genetic changes.The aim of this project is to further assess the CD163 - PRRSV interaction and the potential of the PRRSV to adapt to a deltaSRCR5 pig as well as to generate even more subtle changes to the pig genome than exist in the current deltaSRCR5 pigs. I propose the following strategies to address these questions: to identify domains and amino acids of CD163 interacting with PRRSV; to assess the PRRSV-CD163 signalling and interactome; to serially passage PRRSV on cells from deltaSRCR5 pigs to mimic virus evolution; to produce functional deltaSRCR5 pigs by exon skipping rather than exon deletion.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Pigs Lacking the Scavenger Receptor Cysteine-Rich Domain 5 of CD163 Are Resistant to Porcine Reproductive and Respiratory Syndrome Virus 1 Infection.
缺乏CD163的猪富含清道夫受体的富含半胱氨酸的结构域5具有对猪生殖和呼吸综合征病毒1感染的抗性。
DOI:
10.1128/jvi.00415-18
发表时间:
2018-08-15
期刊:
Journal of virology
影响因子:
5.4
作者:
[Burkard C, Opriessnig T, Mileham AJ, Stadejek T, Ait-Ali T, Lillico SG, Whitelaw CBA, Archibald AL]
通讯作者:
Archibald AL
DOI:
10.1186/s13059-018-1583-1
发表时间:
2018-11-26
期刊:
Genome biology
影响因子:
12.3
作者:
[Tait-Burkard C, Doeschl-Wilson A, McGrew MJ, Archibald AL, Sang HM, Houston RD, Whitelaw CB, Watson M]
通讯作者:
Watson M
Gene edited "superpigs" resist devastating disease
基因编辑的“超级猪”抵抗毁灭性疾病
DOI:
10.25250/thescbr.brk185
发表时间:
2019
期刊:
TheScienceBreaker
影响因子:
--
作者:
[Burkard C]
通讯作者:
Burkard C
DOI:
10.1042/etls20170032
发表时间:
2017-11
期刊:
Emerging topics in life sciences
影响因子:
3.8
作者:
[C. Proudfoot;C. Burkard]
通讯作者:
C. Proudfoot;C. Burkard
Erratum for Burkard et al., "Pigs Lacking the Scavenger Receptor Cysteine-Rich Domain 5 of CD163 Are Resistant to Porcine Reproductive and Respiratory Syndrome Virus 1 Infection".
Burkard 等人的勘误,“缺乏 CD163 清道夫受体富含半胱氨酸结构域 5 的猪对猪繁殖与呼吸综合征病毒 1 感染有抵抗力”。
DOI:
10.1128/jvi.00951-20
发表时间:
2020
期刊:
Journal of virology
影响因子:
5.4
作者:
[Burkard C]
通讯作者:
Burkard C
Interferon-stimulated genes as resilience factors for PRRSV infection
-
批准号:BB/T015179/1
-
项目类别:Research Grant
-
资助金额:$81.92万
-
财政年份:2020
-
负责人:Christine Tait-Burkard
-
依托单位:
A strategic approach to identifying and combating porcine reproductive and respiratory syndrome virus outbreaks and other porcine viral diseases
-
批准号:BB/R013187/1
-
项目类别:Research Grant
-
资助金额:$100.28万
-
财政年份:2018
-
负责人:Christine Tait-Burkard
-
依托单位:
国内基金
海外基金
登录
查看更多内容
利用饱和点突变技术针对CD163基因筛选PRRSV入侵重要氨基酸
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:徐奎
-
依托单位:
猪源化CD163小鼠模型的制备及在PRRSV感染和抗病毒药物筛选中的应用
-
批准号:32172827
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:陈全刚
-
依托单位:
Fractalkine通过靶向调节小胶质细胞CD163/SHH表达促进脑出血后血肿吸收和神经血管修复的研究
-
批准号:82071335
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:贺权威
-
依托单位:
Calpain-1与CD163互作介导PRRSV脱壳及其分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2020
-
负责人:郭春和
-
依托单位:
Calpain-1与CD163互作介导PRRSV脱壳及其分子机制研究
-
批准号:32072695
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:郭春和
-
依托单位:
CD163 SRCR5结构域介导PRRSV感染的分子机制研究
-
批准号:32002267
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:马红芳
-
依托单位:
CD163对脑出血疾病继发性脑损伤的作用及机制研究
-
批准号:81801177
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:孙娜
-
依托单位:
CD163在脑出血后血肿溶解介导的继发脑损伤中的作用和机制研究
-
批准号:81701148
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:刘冉
-
依托单位:
PRRSV结构蛋白GP4与其入侵受体CD163的相互作用机制研究
-
批准号:31602036
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:李睿
-
依托单位:
PRRSV对细胞受体CD163/NMHC-IIA蛋白表达的影响与调控机制
-
批准号:31302060
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:高继明
-
依托单位: